Juvenile myoclonic epilepsy phenotype in a family with Unverricht-Lundborg disease.


Journal

Epileptic disorders : international epilepsy journal with videotape
ISSN: 1950-6945
Titre abrégé: Epileptic Disord
Pays: United States
ID NLM: 100891853

Informations de publication

Date de publication:
01 Aug 2019
Historique:
pubmed: 2 8 2019
medline: 29 1 2020
entrez: 2 8 2019
Statut: ppublish

Résumé

Unverricht-Lundborg disease (ULD), an autosomal recessive progressive myoclonus epilepsy, is due to an expansion, or less commonly a mutation, of the cystatin B (CSTB) gene. We report a clinical and molecular study of a Tunisian ULD family with five affected members presenting with a juvenile myoclonic epilepsy (JME)-like phenotype. The expansion of dodecamers was detected by a deamination/PCR assay. The expression profiles of CSTB and other candidate modifying genes, cathepsin B and cystatin C, were established by quantitative RT-PCR, and their respective transcription levels were compared with those from patients with a classic picture of ULD. Three patients had a fixed phenotype mimicking JME after 29 years of evolution. Only a discrete dysarthria was noticed in the two other patients. No correlation was observed between transcription level and severity of disease. Genetic screening should be performed in patients with a JME-like phenotype, when careful examination reveals discrete atypical signs of JME. This particular phenotype may be due to modifying genes and/or gene-environment interactions which require further clarification.

Identifiants

pubmed: 31368437
pii: epd.2019.1078
doi: 10.1684/epd.2019.1078
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

359-365

Auteurs

Amina Gargouri Berrechid (AG)

Razi Hospital, Department of Neurology, LR 18SP03, Tunis, Université de Tunis El Manar, Faculté de Médecine de Tunis, Tunis, Tunisia.

Mouna Bendjebara (M)

Razi Hospital, Department of Neurology, LR 18SP03, Tunis, Université de Tunis El Manar, Faculté de Médecine de Tunis, Tunis, Tunisia.

Delphine Bouteiller (D)

Institut national de la santé et de la recherche médicale (INSERM), U975, ICM, Hôpital Pitié-Salpêtrière, Paris, Sorbonne Universités, Institut du Cerveau et de la Moelle épinière, ICM, Inserm U1127, CNRS UMR 7225, Paris, Institut du Cerveau et de la Moelle épinière, plateforme de génotypage et de séquençage, Hôpital Pitié-Salpêtrière, Paris.

Amina Nasri (A)

Razi Hospital, Department of Neurology, LR 18SP03, Tunis, Université de Tunis El Manar, Faculté de Médecine de Tunis, Tunis, Tunisia.

Jean-Noël Peuvion (JN)

APHP, Hôpital Pitié-Salpêtrière, Département de Génétique, Paris, France.

Yannick Marie (Y)

Institut national de la santé et de la recherche médicale (INSERM), U975, ICM, Hôpital Pitié-Salpêtrière, Paris, Sorbonne Universités, Institut du Cerveau et de la Moelle épinière, ICM, Inserm U1127, CNRS UMR 7225, Paris, Institut du Cerveau et de la Moelle épinière, plateforme de génotypage et de séquençage, Hôpital Pitié-Salpêtrière, Paris.

Stéphanie Baulac (S)

Institut national de la santé et de la recherche médicale (INSERM), U975, ICM, Hôpital Pitié-Salpêtrière, Paris, Sorbonne Universités, Institut du Cerveau et de la Moelle épinière, ICM, Inserm U1127, CNRS UMR 7225, Paris.

Saloua Mrabet (S)

Razi Hospital, Department of Neurology, LR 18SP03, Tunis, Université de Tunis El Manar, Faculté de Médecine de Tunis, Tunis, Tunisia.

Théo Ribierre (T)

Institut national de la santé et de la recherche médicale (INSERM), U975, ICM, Hôpital Pitié-Salpêtrière, Paris, Sorbonne Universités, Institut du Cerveau et de la Moelle épinière, ICM, Inserm U1127, CNRS UMR 7225, Paris.

Cecile Cazeneuve (C)

APHP, Hôpital Pitié-Salpêtrière, Département de Génétique, Paris, France.
Razi Hospital, Department of Neurology, LR 18SP03, Tunis, Université de Tunis El Manar, Faculté de Médecine de Tunis, Tunis, Tunisia.

Eric Leguern (E)

Institut national de la santé et de la recherche médicale (INSERM), U975, ICM, Hôpital Pitié-Salpêtrière, Paris, Sorbonne Universités, Institut du Cerveau et de la Moelle épinière, ICM, Inserm U1127, CNRS UMR 7225, Paris, APHP, Hôpital Pitié-Salpêtrière, Département de Génétique, Paris, France.

Riadh Gouider (R)

Razi Hospital, Department of Neurology, LR 18SP03, Tunis, Université de Tunis El Manar, Faculté de Médecine de Tunis, Tunis, Tunisia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH